Kwality [KPL] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Kwality
BSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kwality wins in 9 metrics, Sun Pharmaceutical wins in 10 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kwality | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.88 | 37.73 | Kwality |
| Price-to-Book Ratio | 3.60 | 5.42 | Kwality |
| Debt-to-Equity Ratio | 42.85 | 3.26 | Sun Pharmaceutical |
| PEG Ratio | 0.51 | -1.94 | Sun Pharmaceutical |
| EV/EBITDA | 11.86 | 23.98 | Kwality |
| Profit Margin (TTM) | 10.81% | 19.29% | Sun Pharmaceutical |
| Operating Margin (TTM) | 17.75% | 24.34% | Sun Pharmaceutical |
| EBITDA Margin (TTM) | 17.75% | 24.34% | Sun Pharmaceutical |
| Return on Equity | 15.19% | 15.08% | Kwality |
| Return on Assets (TTM) | 8.91% | 11.87% | Sun Pharmaceutical |
| Free Cash Flow (TTM) | $277.15M | $119.44B | Sun Pharmaceutical |
| Dividend Yield | N/A | 1.26% | N/A |
| 1-Year Return | 16.43% | -13.00% | Kwality |
| Price-to-Sales Ratio (TTM) | 2.36 | 7.28 | Kwality |
| Enterprise Value | $10.46B | $3,678.87B | Sun Pharmaceutical |
| EV/Revenue Ratio | 2.60 | 6.84 | Kwality |
| Gross Profit Margin (TTM) | 47.94% | 79.58% | Sun Pharmaceutical |
| Revenue per Share (TTM) | $387 | $224 | Kwality |
| Earnings per Share (Diluted) | $41.81 | $43.23 | Sun Pharmaceutical |
| Beta (Stock Volatility) | -0.31 | 0.28 | Kwality |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Kwality vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kwality | -4.97% | -0.40% | -2.23% | -20.74% | 17.55% | 6.68% |
| Sun Pharmaceutical | -0.10% | 4.12% | 4.66% | -1.50% | -0.70% | -12.45% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kwality | 16.43% | 111.98% | 1,447.16% | 4,012.00% | 4,012.00% | 4,012.00% |
| Sun Pharmaceutical | -13.00% | 69.49% | 239.84% | 85.82% | 711.29% | 2,598.03% |
News Based Sentiment: Kwality vs Sun Pharmaceutical
Kwality
News based Sentiment: MIXED
Kwality Pharmaceuticals reported impressive FY25 results, but Q1 FY26 showed a slight decline in income. While long-term performance remains strong and analysts are largely positive, the recent short-term weakness introduces some uncertainty, making the overall investment story mixed.
Sun Pharmaceutical
News based Sentiment: MIXED
October was a month of significant contrasts for Sun Pharma. While the company demonstrated revenue growth and made strategic acquisitions, the imposition of a 100% US tariff on Indian pharmaceuticals presents a major headwind. This combination of positive and negative developments creates a mixed investment outlook.
Performance & Financial Health Analysis: Kwality vs Sun Pharmaceutical
| Metric | KPL | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹10.00B | ₹4.01T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 10,178 | 3,168,435 |
| 90 Day Avg. Volume | 10,731 | 2,778,768 |
| Last Close | ₹879.25 | ₹1,653.10 |
| 52 Week Range | ₹596.05 - ₹1,235.00 | ₹1,548.00 - ₹1,947.00 |
| % from 52W High | -28.81% | -15.10% |
| All-Time High | ₹1,235.00 (Jul 07, 2025) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -28.81% | -15.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.39% | 0.10% |
| Quarterly Earnings Growth | 0.43% | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.19% |
| Operating Margin (TTM) | 0.18% | 0.24% |
| Return on Equity (TTM) | 0.15% | 0.15% |
| Debt to Equity (MRQ) | 42.85 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹254.23 | ₹300.99 |
| Cash per Share (MRQ) | ₹14.22 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹387.34M | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹398.45M | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.26% |
| Last 12-Month Dividend | ₹0.00 | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Kwality vs Sun Pharmaceutical
| Metric | KPL | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.88 | 37.73 |
| Forward P/E | N/A | 49.91 |
| PEG Ratio | 0.51 | -1.94 |
| Price to Sales (TTM) | 2.36 | 7.28 |
| Price to Book (MRQ) | 3.60 | 5.42 |
| Market Capitalization | ||
| Market Capitalization | ₹10.00B | ₹4.01T |
| Enterprise Value | ₹10.46B | ₹3.68T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.60 | 6.84 |
| Enterprise to EBITDA | 11.86 | 23.98 |
| Risk & Other Metrics | ||
| Beta | -0.31 | 0.28 |
| Book Value per Share (MRQ) | ₹254.23 | ₹300.99 |
Financial Statements Comparison: Kwality vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KPL | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹1.11B | ₹137.86B |
| Cost of Goods Sold | ₹580.34M | ₹28.15B |
| Gross Profit | ₹534.45M | ₹109.71B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹194.12M | ₹33.72B |
| EBITDA | ₹245.52M | ₹47.66B |
| Pre-Tax Income | ₹170.28M | ₹31.73B |
| Income Tax | ₹51.08M | ₹8.70B |
| Net Income (Profit) | ₹119.20M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KPL | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹120.20M | ₹102.69B |
| Total Current Assets | ₹2.84B | ₹526.24B |
| Total Current Liabilities | ₹1.70B | ₹181.94B |
| Long-Term Debt | ₹151.19M | ₹3.58B |
| Total Shareholders Equity | ₹2.62B | ₹724.86B |
| Retained Earnings | ₹2.44B | ₹578.62B |
| Property, Plant & Equipment | ₹458.28M | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KPL | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | ₹-36.22M | N/A |
| Capital Expenditures | ₹-13.09M | N/A |
| Free Cash Flow | ₹-14.05M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KPL | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,178 | 3,168,435 |
| Average Daily Volume (90 Day) | 10,731 | 2,778,768 |
| Shares Outstanding | 10.38M | 2.40B |
| Float Shares | 2.30M | 1.06B |
| % Held by Insiders | 0.78% | 0.56% |
| % Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Kwality vs Sun Pharmaceutical
| Metric | KPL | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹21.00 |
| Last 12-Month Dividend Yield | N/A | 1.26% |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹14.67 |
| 3-Year Avg Dividend Yield | N/A | 0.46% |
| 3-Year Total Dividends | ₹0.00 | ₹44.00 |
| Ex-Dividend Date | N/A | Jul 07, 2025 |